共 50 条
- [32] Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand? JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (10): : 1281 - 1292
- [35] Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? The experience of Italian centers TUMORI JOURNAL, 2015, 101 (02): : 139 - 143
- [39] Sorafenib as second-line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma JGH OPEN, 2020, 4 (06): : 1135 - 1139